Geron (GERN) Price to Book (2010 - 2026)
Geron's (GERN) quarterly Price to Book came in at 3.76 in Q2 2026, up 8.52% year-over-year from 3.47 in Q2 2025, and down 9.6% quarter-over-quarter from 4.16 in Q1 2026.
Analysis
Geron (GERN) Price to Book (2010 - 2026) Analysis & Trends
Geron has disclosed Price to Book across 17 years of filings, most recently posting 3.76 for Q2 2026.
- In Q2 2026, Price to Book rose 8.52% year-over-year to 3.76; the TTM figure through Jun 2026 stood at 3.76 (up 8.52% YoY), while the FY2025 annual figure was 3.74, down 51.17% from the prior year.
- Price to Book came in at 3.76 for Q2 2026 at Geron, down from 4.16 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 11.81 in Q4 2022 to a low of 3.39 in Q1 2023.
- Average Price to Book over 5 years is 5.59, with a median of 4.4 recorded in 2023.
- Year-over-year, Price to Book jumped 277.88% in 2022 and tumbled 62.55% in 2025.
- Over 5 years, Price to Book stood at 11.81 in 2022, then tumbled by 60.72% to 4.64 in 2023, then soared by 65.14% to 7.66 in 2024, then slumped by 51.17% to 3.74 in 2025, then climbed by 0.6% to 3.76 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 3.76 in Q2 2026, 4.16 in Q1 2026, and 3.74 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.76 |
| Mar 31, 2026 | 4.16 |
| Dec 31, 2025 | 3.74 |
| Sep 30, 2025 | 3.52 |
| Jun 30, 2025 | 3.47 |
| Mar 31, 2025 | 3.78 |
| Dec 31, 2024 | 7.66 |
| Sep 30, 2024 | 9.39 |
| Jun 30, 2024 | 8.33 |
| Mar 31, 2024 | 5.68 |
| Dec 31, 2023 | 4.64 |
| Sep 30, 2023 | 3.96 |
| Jun 30, 2023 | 5.63 |
| Mar 31, 2023 | 3.39 |
| Dec 31, 2022 | 11.81 |
| Sep 30, 2022 | 8.25 |
| Jun 30, 2022 | 4.12 |
| Mar 31, 2022 | 5.27 |
| Dec 31, 2021 | 3.12 |
| Sep 30, 2021 | 2.91 |